OraSure Technologies Net Profit Margin 2010-2025 | OSUR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

OraSure Technologies net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

OraSure Technologies net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$226.7B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$145.9B
EssilorLuxottica (ESLOY)	$145.2B
Medtronic (MDT)	$119B
Lonza Group Ag (LZAGY)	$48.3B
Haleon (HLN)	$43.4B
ResMed (RMD)	$41.9B
Agilent Technologies (A)	$33.6B
GE HealthCare Technologies (GEHC)	$33.4B
Terumo (TRUMY)	$27.9B
Koninklijke Philips (PHG)	$26.4B
Insulet (PODD)	$22.7B
Zimmer Biomet Holdings (ZBH)	$20.3B
Smith & Nephew SNATS (SNN)	$15.9B
Baxter (BAX)	$12.1B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.7B
Lantheus Holdings (LNTH)	$3.8B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.2B
Perrigo (PRGO)	$3.2B
ICU Medical (ICUI)	$3B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.2B
Curaleaf Holdings (CURLF)	$1.9B
AtriCure (ATRC)	$1.8B
QuidelOrtho (QDEL)	$1.8B